That is why I wonder if they will sell off the Marqibo asset to big pharma & get a buyer for the pipleline as the year end nears. I agree they aren't going to take a hit on TLON...and perhaps the Allos mishap will help us because if they are smart they will offset Allos losses with TLON gains.
Market Data 
Markets 
AI
